Awada A - Search Results

1

Metronomic chemotherapy for patients with metastatic breast cancer: Review of effectiveness and potential use during pandemics.

Fares JE, El Tomb P, Khalil LE, Atwani RW, Moukadem HA, Awada A, El Saghir NS. Fares JE, et al. Among authors: awada a. Cancer Treat Rev. 2020 Sep;89:102066. doi: 10.1016/j.ctrv.2020.102066. Epub 2020 Jun 29. Cancer Treat Rev. 2020. PMID: 32769038 Review.

2

An EORTC pilot study of filgrastim (recombinant human granulocyte colony stimulating factor) as support to a high dose-intensive epiadriamycin-cyclophosphamide regimen in chemotherapy-naive patients with locally advanced or metastatic breast cancer.

Piccart MJ, Bruning P, Wildiers J, Awada A, Schornagel JH, Thomas J, Tomiak E, Bartholomeus S, Witteveen PO, Paridaens R. Piccart MJ, et al. Among authors: awada a. Ann Oncol. 1995 Sep;6(7):673-7. doi: 10.1093/oxfordjournals.annonc.a059283. Ann Oncol. 1995. PMID: 8664188 Free article. Clinical Trial.

3

Breast cancer therapies in development. A review of their pharmacology and clinical potential.

de Valeriola D, Awada A, Roy JA, Di Leo A, Biganzoli L, Piccart M. de Valeriola D, et al. Among authors: awada a. Drugs. 1997 Sep;54(3):385-413. doi: 10.2165/00003495-199754030-00003. Drugs. 1997. PMID: 9279502 Review.

4

Mitomycin C and vinblastine in combination with amifostine in metastatic breast cancer. A feasibility study of the EORTC--Investigational Drug Branch for Breast Cancer (IDBBC).

Kusenda Z, Kerger J, Awada A, Geurs F, Van Vreckem A, Habboubi N, Piccart MJ. Kusenda Z, et al. Among authors: awada a. Support Care Cancer. 1997 Sep;5(5):414-6. doi: 10.1007/s005200050101. Support Care Cancer. 1997. PMID: 9322355 Clinical Trial.

5

An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes.

Awada A, Biganzoli L, Cufer T, Beex L, Lohrisch C, Batter V, Hamilton A, Nooij M, Piccart M. Awada A, et al. Eur J Cancer. 2002 Apr;38(6):773-8. doi: 10.1016/s0959-8049(01)00427-0. Eur J Cancer. 2002. PMID: 11937310 Clinical Trial.

6

New cytotoxic agents and molecular-targeted therapies in the treatment of metastatic breast cancer.

Awada A. Awada A. Forum (Genova). 2002;12(1):4-15. Forum (Genova). 2002. PMID: 12634907 Review.

7

The pipeline of new anticancer agents for breast cancer treatment in 2003.

Awada A, Cardoso F, Atalay G, Giuliani R, Mano M, Piccart MJ. Awada A, et al. Crit Rev Oncol Hematol. 2003 Oct;48(1):45-63. doi: 10.1016/s1040-8428(03)00171-9. Crit Rev Oncol Hematol. 2003. PMID: 14585483 Review.

8

Adjuvant anthracycline-based chemotherapy for early breast cancer: do the dose and schedule matter?

Mano MS, Awada A, Kerr J, Canney P. Mano MS, et al. Among authors: awada a. Cancer Treat Rev. 2005 Apr;31(2):69-78. doi: 10.1016/j.ctrv.2004.11.001. Epub 2005 Jan 22. Cancer Treat Rev. 2005. PMID: 15847977 Review.

9

Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the "do ut des" paradigm).

de Castro Junior G, Puglisi F, de Azambuja E, El Saghir NS, Awada A. de Castro Junior G, et al. Among authors: awada a. Crit Rev Oncol Hematol. 2006 Jul;59(1):40-50. doi: 10.1016/j.critrevonc.2006.02.007. Epub 2006 Apr 4. Crit Rev Oncol Hematol. 2006. PMID: 16600618 Review.

10

Novel treatment strategies for soft tissue sarcoma.

Kasper B, Gil T, D'Hondt V, Gebhart M, Awada A. Kasper B, et al. Among authors: awada a. Crit Rev Oncol Hematol. 2007 Apr;62(1):9-15. doi: 10.1016/j.critrevonc.2006.11.008. Epub 2006 Dec 1. Crit Rev Oncol Hematol. 2007. PMID: 17141519 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

546 results

Search Page